Literature DB >> 8922580

Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients.

H C Ryley1, B Ojeniyi, N Høiby, J Weeks.   

Abstract

Burkholderia cepacia isolates from nine of the ten Danish cystic fibrosis (CF) patients known between 1975 and the present day to carry this organism were investigated. Eight distinct genotypes were found with polymerase chain reaction ribotyping and pulsed-field gel electrophoresis. The results indicate that there is little patient-to-patient cross-infection with Burkholderia cepacia within the Danish CF population, even though the majority of patients attend the same CF clinic on a regular basis.

Entities:  

Mesh:

Year:  1996        PMID: 8922580     DOI: 10.1007/bf01691967

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients.

Authors:  M Nir; H K Johansen; N Høiby
Journal:  Acta Paediatr       Date:  1992-12       Impact factor: 2.299

2.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

3.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

4.  Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping.

Authors:  H C Ryley; L Millar-Jones; A Paull; J Weeks
Journal:  J Med Microbiol       Date:  1995-12       Impact factor: 2.472

5.  Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Authors:  D L Smith; L B Gumery; E G Smith; D E Stableforth; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

6.  Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment.

Authors:  M C Fisher; J J LiPuma; S E Dasen; G C Caputo; J E Mortensen; K L McGowan; T L Stull
Journal:  J Pediatr       Date:  1993-11       Impact factor: 4.406

7.  Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  B Ojeniyi; N Høiby; V T Rosdahl
Journal:  APMIS       Date:  1991-06       Impact factor: 3.205

8.  Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.

Authors:  D Grothues; U Koopmann; H von der Hardt; B Tümmler
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

9.  Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group.

Authors:  D A Pegues; L A Carson; O C Tablan; S C FitzSimmons; S B Roman; J M Miller; W R Jarvis
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

10.  Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.

Authors:  S Steinbach; L Sun; R Z Jiang; P Flume; P Gilligan; T M Egan; R Goldstein
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

View more
  3 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom.

Authors:  Jane F Turton; Mary E Kaufmann; Nazim Mustafa; Sonia Kawa; Fiona E Clode; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 3.  Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Authors:  A Holmes; J Govan; R Goldstein
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.